Inhibition of salivary secretion by activation of cannabinoid receptors

Experimental Biology and Medicine

Volumn 231, Issue 8, 2006, Pages 1421-1429

  Prestifilippo, Juan Pablo ^a,b   Fernández Solari, Javier ^a,b   De La Cal, Carolina ^b   Iribarne, María ^c   Suburo, Angela M ^c   Rettori, Valeria ^a   McCann, Samuel M ^a   Elverdin, Juan Carlos ^b  

^a Centre de Estudios Farmacologicos y Botanicos   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^c UNIVERSIDAD AUSTRAL   (Argentina)

Author keywords

AM251; AM630; Anandamide; cAMP; Submandibular gland

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 6 IODO 3 (4 METHOXYBENZOYL) 2 METHYL 1 (2 MORPHOLINOETHYL)INDOLE; ADENYLATE CYCLASE; ANANDAMIDE; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR; CYCLIC AMP; ENDOCANNABINOID; FORSKOLIN; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; METHACHOLINE; NORADRENALIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; ENZYME INHIBITION; ENZYME LOCALIZATION; IMMUNOREACTIVITY; MALE; NONHUMAN; PROTEIN BINDING; RAT; RECEPTOR BINDING; SALIVATION; SIGNAL TRANSDUCTION; SUBMANDIBULAR GLAND;

CANNABIS SATIVA; MAMMALIA;

EID: 33748335454     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1177/153537020623100816     Document Type: Article

References (40)

1. Devane WA, Dysarz FA III, Johnson MR, Melvin LS, Howlett AC. Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 34:605-613, 1988.
2. Herkenham M, Lynn AB, Little MD, Johnson MR, Melvin LS, de Costa BR, Rice KC. Cannabinoid receptor localization in brain. Proc Natl Acad Sci U S A 87:1932-1936, 1990.
3. Pertwee RG, Ed. Cannabinoid Receptors. London: Academic Press, pp1-34, 1995.
4. Munro S, Thomas KL, Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 365:61-65, 1993.
5. Howlett AC, Fleming RM. Cannabinoid inhibition of adenylate cyclase: pharmacology of the response in neuroblastoma cell membranes. Mol Pharmacol 26:532-538, 1984.
6. Mechoulam R, Fride E, Di Marzo V. Endocannabinoids. Eur J Pharmacol 359:1-18, 1998.
7. 1 receptors. Eur J Pharmacol 307:331-338, 1996.
8. Lan R, Gatley J, Lu Q, Fan P, Fernando SR, Volkow ND, Pertwee R, Makriyannis A. Design and synthesis of the CB1 selective cannabinoid antagonist AM281: a potential human SPECT ligand. AAPS PharmSci 1:E4, 1999.
9. Rinaldi-Carmona M, Barth F, Heaulme M, Alonso R, Shire D, Congy C, Soubrie P, Breliere JC, Le Fur G. Biochemical and pharmacological characterisation of SR141716A, the first potent and selective brain cannabinoid receptor antagonist. Life Sci 56:1941-1947, 1995.
10. Rinaldi-Carmona M, Barth F, Heaulme M, Shire D, Calandra B, Congy C, Martinez S, Maruani J, Neliat G, Caput D, Ferrara P, Soubrie P, Lefue G. SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett 350:240-244, 1994.
11. Felder CC, Joyce KE, Briley EM, Glass M, Mackie KP, Fahey KJ, Cullinan GJ, Hunden DC, Johnson DW, Chaney MO, Koppel GA, Brownstein M. LY320135, a novel cannabinoid CB1 receptor antagonist, unmasks coupling of the CB1 receptor to stimulation of cAMP accumulation. J Pharmacol Exp Ther 284:291-297, 1998.
12. Pertwee R, Griffin G, Fernando S, Li X, Hill A, Makriyannis A. AM630, a competitive cannabinoid receptor antagonist. Life Sci 56:1949-1955, 1995.
13. 2 receptor absence in the rat central nervous system. Eur J Pharmacol 377:117-125, 1999.
14. 35S] GTPγS binding in the mouse brain. Eur J Pharmacol 321:R1-R3, 1997.
15. Tandler B, Phillips CJ. Microstructure of mammalian salivary glands and its relationship to diet. In: Garret JR, Ekstrom J, Anderson LC, Eds. Glandular Mechanisms of Salivary Secretion: Oral Frontiers on Biology. Basel: Karger, Vol 10:pp21-35, 1998.
16. Thaysen JH, Thorn NA, Schwartz IL. Excretion of sodium, potassium, chloride and carbon dioxide in human parotid saliva. Am J Physiol 178:155-159, 1954.
17. Cook DI, Young JA. Fluid and electrolyte secretion by salivary glands. In: Handbook of Physiology: The Gastrointestinal System: Salivary, Gastric, Pancreatic, and Hepatobilary Secretion. Bethesda: American Physiological Society, Vol 3:pp1-23, 1989.
18. Lung MA. Autonomic nervous control of myoepithelial cells and secretion in submandibular gland of anaesthetized dogs. J Physiol 546(Pt 3):837-850, 2003.
19. Man YG, Ball WD, Marchetti L, Hand AR. Contributions of intercalated duct cells to the normal parenchyma of submandibular glands of adult rats. Anat Rec 263:202-214, 2001.
20. Ishac EJ, Jiang L, Lake KD, Varga K, Abood ME, Kunos G. Inhibition of exocytotic noradrenaline release by presynaptic cannabinoid CB1 receptors on peripheral sympathetic nerves. Br J Pharmacol 118:2023-2028, 1996.
21. Szabo B, Nordheim U, Niederhoffer N. Effects of cannabinoids on sympathetic and parasympathetic neuroeffector transmission in the rabbit heart. J Pharmacol Exp Ther 297:819-826, 2001.
22. 9-tetrahydrocannabinol in the rat submaxillary gland in vitro. Arch Int Phamacodyn Ther 235:180-186, 1978.
23. 9-THC) on mammalian salivary flow. J Pharmacol Exp Ther 206:567-573, 1978.
24. Barthel LK, Raymond PA. Improved method for obtaining 3-microns cryosections for immunocytochemistry. J Histochem Cytochem 38:1383-1388, 1990.
25. Suburo AM, Wheatley SC, Horn DA, Gibson SJ, Jahn R, Fischer-Colbrie R, Wood JN, Latchman DS, Polak JM. Intracellular redistribution of neuropeptides and secretory proteins during differentiation of neuronal cell lines. Neuroscience 46:881-889, 1992.
26. Bianciotti LG, Elverdin JC, Vatta MS, Colatrella C, Fernandez BE. Atrial natriuretic factor enhances induced salivary secretion in the rat. Regul Pept 49:195-202, 1994.
27. 1 in the human prostate gland. Prostate 54:95-102, 2003.
28. Porcella A, Marchese G, Casu MA, Rocchitta A, Lai ML, Gessa GL, Pani L. Evidence for functional CB1 cannabinoid receptor expressed in the rat thyroid [published correction appears in Eur J Endocrinol 147:434, 2002]. Eur J Endocrinol 147:255-261, 2002.
29. 1 receptors in the mouse gastroenteric tract. Eur J Pharmacol 459:97-105, 2003.
30. MacNaughton WK, Van Sickle MD, Keenan CM, Cushing K, Mackie K, Sharkey KA. Distribution and function of the cannabinoid-1 receptor in the modulation of ion transport in the guinea pig ileum: relationship to capsaicin-sensitive nerves. Am J Physiol Gastrointest Liver Physiol 286:G863-G871, 2004.
31. Baum BJ. Neurotransmitter control of secretion. J Dent Res 66:628-632, 1987.
32. 2+ levels in rat submandibular granular ducts and acini. Am J Physiol 261:G359-G363, 1991.
33. Abdollahi M, Simaiee B. Stimulation by theophylline and sidelnafil of rat submandibular secretion of protein, epidermal growth factor and flow rate. Pharmacol Res 48:445-449, 2003.
34. Johannessen M, Delghandi MP, Moens U. What turns CREB on? Cell Signal 16:1211-1227, 2004.
35. Kim J, Amano O, Wakayama T, Takahagi H, Iseki S. The role of cyclic AMP response element-binding protein in testosterone-induced differentiation of granular convoluted tubule cells in the rat submandibular gland. Arch Oral Biol 46:495-507, 2001.
36. Moreira TS, Thomaz AC, De Luca LA Jr, Renzi A, Menani JV. Moxonidine reduces pilocarpine-induced salivation in rats. Auton Neurosci 91:32-36, 2001.
37. Renzi A, Colombari E, Mattos Filho TR, Silveira JE, Saad WA, Camargo LA, De Luca LA Jr, Derobio JG, Menani JV. Involvement of the central nervous system in the salivary secretion by pilocarpine in rats. J Dental Res 72:1481-1484, 1993.
38. Renzi A, De Luca LA Jr, Menani JV. Lesions of the lateral hypothalamus impair pilocarpine-induced salivation in rats. Brain Res Bull 58:455-459, 2002.
39. Moreita TS, Takakura AC, De Luca LA Jr, Renzi A, Menani JV. Inhibition of pilocarpine-induced salivation in rats by central noradrenaline. Arch Oral Biol 47:429-434, 2002.
40. Wright K, Rooney N, Feeney M, Tate J, Robertson D, Welham M, Ward S. Differential expression of cannabinoid receptors in the human colon: cannabinoids promote epithelial wound healing. Gastroenterology 129:437-453, 2005.